5/13
10:56 am
lab
Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
04:12 pm
lab
Standard BioTools Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Standard BioTools Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/8
04:01 pm
lab
Standard BioTools Reports First Quarter 2024 Financial Results
Medium
Report
Standard BioTools Reports First Quarter 2024 Financial Results
4/25
08:10 am
lab
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth [Yahoo! Finance]
Medium
Report
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth [Yahoo! Finance]
4/25
08:10 am
lab
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]
Neutral
Report
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]
4/25
08:01 am
lab
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
Medium
Report
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
4/25
08:00 am
lab
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
Medium
Report
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
4/16
08:08 am
lab
Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic? [Yahoo! Finance]
Neutral
Report
Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic? [Yahoo! Finance]
4/16
08:00 am
lab
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at TD Cowen. They set a "buy" rating and a $3.50 price target on the stock.
Neutral
Report
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at TD Cowen. They set a "buy" rating and a $3.50 price target on the stock.
4/8
08:14 am
lab
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging [Yahoo! Finance]
Medium
Report
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging [Yahoo! Finance]
4/8
08:00 am
lab
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
Medium
Report
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
4/4
08:03 am
lab
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $3.25 price target on the stock.
Medium
Report
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $3.25 price target on the stock.
4/3
04:01 pm
lab
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
Low
Report
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
4/2
07:27 am
lab
Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)? [Yahoo! Finance]
Low
Report
Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)? [Yahoo! Finance]
3/19
06:32 am
lab
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB) [Yahoo! Finance]
Low
Report
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB) [Yahoo! Finance]
3/18
09:45 am
lab
Standard Biotools exchanges all outstanding Series B convertible preferred stock for common stock [Seeking Alpha]
Low
Report
Standard Biotools exchanges all outstanding Series B convertible preferred stock for common stock [Seeking Alpha]
3/18
08:17 am
lab
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock [Yahoo! Finance]
Low
Report
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock [Yahoo! Finance]
3/18
08:12 am
lab
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
Medium
Report
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
3/5
08:37 am
lab
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/28
04:53 pm
lab
Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ... [Yahoo! Finance]
Medium
Report
Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ... [Yahoo! Finance]
2/28
04:13 pm
lab
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/28
04:01 pm
lab
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
Medium
Report
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
2/26
08:18 am
lab
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing [Yahoo! Finance]
Low
Report
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing [Yahoo! Finance]
2/26
08:00 am
lab
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
Low
Report
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
2/22
04:05 pm
lab
Standard BioTools to Participate in Upcoming Investor Conferences
Medium
Report
Standard BioTools to Participate in Upcoming Investor Conferences